Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p.
Li, Xiang
Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p. [electronic resource] - Toxicology and applied pharmacology 06 2020 - 114998 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1096-0333
10.1016/j.taap.2020.114998 doi
Antineoplastic Agents--pharmacology
Blotting, Western
Carcinoma, Hepatocellular--drug therapy
Cell Line, Tumor
DNA (Cytosine-5-)-Methyltransferase 1--drug effects
Flavonoids--pharmacology
Flow Cytometry
Humans
Liver Neoplasms--drug therapy
MicroRNAs--drug effects
Reverse Transcriptase Polymerase Chain Reaction
Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p. [electronic resource] - Toxicology and applied pharmacology 06 2020 - 114998 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1096-0333
10.1016/j.taap.2020.114998 doi
Antineoplastic Agents--pharmacology
Blotting, Western
Carcinoma, Hepatocellular--drug therapy
Cell Line, Tumor
DNA (Cytosine-5-)-Methyltransferase 1--drug effects
Flavonoids--pharmacology
Flow Cytometry
Humans
Liver Neoplasms--drug therapy
MicroRNAs--drug effects
Reverse Transcriptase Polymerase Chain Reaction